Post-operative PainNCT02555423
The Effects of Serratus Plane Block Performed Under Direct Vision on Post-operative Pain in Breast Surgery
A study testing Local anaesthetic - chirocaine in people with Post-operative Pain and Serratus Block, run by Kingston Hospital NHS Trust.
Trial summary
The aim of the study is to determine the effectiveness of serratus place block in the control of post-operative pain following mastectomy. The investigators will compare one group of patients receiving serratus plane block and wound infiltration to a control group receiving a saline injection into serratus anterior… Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Post-operative Pain, Serratus Block, Breast Surgery
- What is being tested?
- Local anaesthetic - chirocaine
- How many people
- Not given
- Where
- No sites listed yet
- Study dates
- Oct 2015to Apr 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Adult, Older adult
Who may be able to join
- Patients who undergo mastectomy +/- sentinel node biopsy +/- axillary clearance +/- implant reconstruction will be eligible for the study
Who cannot join
- Patients under the age of 18.
About this study
The aim of the study is to determine the effectiveness of serratus place block in the control of post-operative pain following mastectomy. The investigators will compare one group of patients receiving serratus plane block and wound infiltration to a control group receiving a saline injection into serratus anterior and wound infiltration with local anaesthetic only. The investigators will compare our results to the National Mastectomy and Breast Reconstruction Audit's reported rate of 6.2% of patients reporting severe pain following mastectomy to see if there is an improvement of the national standard. In the serratus block group, the investigators expect a 50% decrease in the number of patients who report severe pain day one post operatively.
Read the detailed description
Patients who undergo mastectomy +/- sentinel node biopsy +/- axillary clearance +/- implant reconstruction will be eligible for the study. Patients will be consented by Mr Davies preoperatively in the breast clinic at Kingston Hospital to be randomly allocated to one of two groups.
The study will be double blinded and patients will be randomly allocated in to one of two groups as detailed below:
Group 1 - Control Group The first group will act as the control group and will receive wound infiltration with the full amount of local anaesthetic (40mls) around the drain sites and axillary wound, if present, as is standard practice. They will also receive a 20ml injection of 0.9% saline deep to serratus anterior under direct observation. Infiltration of saline will be delivered into 2-3 muscular slips (typically ribs 4-6) in the anterior axillary line. The local anaesthetic will be prepared according to body weight and a dose of 0.375% of chirocaine will be used with the addition of 1:200000 adrenaline and 1 microgram/kg of clonidine.
Group 2 - Serratus Plane Block Group
The second group will receive a serratus plane block and wound infiltration as described below:
The serratus plane block will be conducted by injecting 50% of the total available chirocaine 0.375% with adrenaline and clonidine (20mls) deep to serratus anterior under direct observation. Infiltration will be delivered into 2-3 muscular slips (typically ribs 4-6) in the anterior axillary line. The remaining 50% of local anaesthetic (20mls) will be administered by wound infiltration around the drain sites and axillary wound if present along with a 20ml 0.9% saline injection.
For clarity, please see the table summary below detailing the volumes and locations of local anaesthetic and saline injections in both groups:
20ml local anaesthetic delivered as a serratus block 20ml Saline delivered deep to serratus anterior 20ml local anaesthetic and 20ml saline wound and drain site infiltration 40ml local anaesthetic wound and drain site infiltration Control Group X √ X √ Serratus Group √ X √ X
The purpose of the saline injections is to blind the trial to the surgeon delivering the serratus block.
The anaesthesia for all patients in both groups will be induced using a combination of 0.25mg/kg ketamine, propofol and fentanyl according to standard anaesthetic protocol. All patients will receive 10mg IM morphine intraoperatively. All patients will have regular simple analgesia such as paracetamol and ibuprofen and PRN opiates (tramadol 50-100mg PRN 8 hourly) prescribed for post-operative adjunct pain management.
Patients will be blinded to which group they are randomly allocated to. Written consent and information sheets will be provided to patients and a letter sent to their GP confirming participation in the study.
Data on pain scores and the use of analgesia in recovery, the use of analgesia overnight, the presence of nausea and the pain score and mobilisation status one day after the operation will be collected. The pain score will be assessed using a standard numerical rating scale from 0-10 to score their pain subjectively where:
- 0 = No Pain
- 1-3 = Mild Pain (interferes a little with activities of daily living)
- 4-6 = Moderate Pain (interferes significantly with activities of daily living)
- 7-10 = Severe Pain (unable to perform activities of daily living)
Patients will also be followed up and one week and 3 months after their surgery to determine their recovery and the presence of any pain. This data will be collected using the FACT - B: Quality of Life Assessment 1 questionnaire.
All collected data will only be stored on NHS trust computer systems.
- Conditions
- Post-operative Pain, Serratus Block, Breast Surgery
- Being tested
- Local anaesthetic - chirocaine
- Medical subject headings
- Pain, Postoperative
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Local anaesthetic - chirocaineDrug
What is being measured
The primary outcome is the main question the study is designed to answer.
To assess the serratus plane block's effectiveness in the management of post operative pain following mastectomy when compared to wound infiltration alone
Measured: 18 months
Secondary outcomes (1)
To determine the proportion of patients receiving a serratus plane block during mastectomy who go on to develop chronic pain syndromes compared to patients receiving wound infiltration alone
Measured: 18 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Sep 2015 (estimated)
- Study startOct 2015
- Primary completionApr 2017 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Post-operative PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
Sponsor and investigators
- Lead sponsor
- Kingston Hospital NHS Trust
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Marcus Hards, Kingston Hospital NHS Trust
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02555423
- Sponsor's protocol ID
- 179669
- Status last verified
- Sep 2015
- First submitted
- 17 Sep 2015
- Last updated
- 21 Sep 2015
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Sep 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effects of Serratus Plane Block Performed Under Direct Vision on Post-operative Pain in Breast Surgery
- ClinicalTrials.gov ID
- NCT02555423
- Acronym / sponsor ID
- 179669
- Conditions
- Post-operative Pain, Serratus Block, Breast Surgery
- Study type
- Interventional
- Recruitment status
- Unknown status
- Lead sponsor
- Kingston Hospital NHS TrustUniversity, hospital or other
- Study start
- Oct 2015
- Primary completion
- Apr 2017 (estimated)
- First posted
- 21 Sep 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the study is to determine the effectiveness of serratus place block in the control of post-operative pain following mastectomy. The investigators will compare one group of patients receiving serratus plane block and wound infiltration to a control group receiving a saline injection into serratus anterior and wound infiltration with local anaesthetic only. The investigators will compare our results to the National Mastectomy and Breast Reconstruction Audit's reported rate of 6.2% of patients reporting severe pain following mastectomy to see if there is an improvement of the national standard. In the serratus block group, the investigators expect a 50% decrease in the number of patients who report severe pain day one post operatively.
Detailed description
Patients who undergo mastectomy +/- sentinel node biopsy +/- axillary clearance +/- implant reconstruction will be eligible for the study. Patients will be consented by Mr Davies preoperatively in the breast clinic at Kingston Hospital to be randomly allocated to one of two groups.
The study will be double blinded and patients will be randomly allocated in to one of two groups as detailed below:
Group 1 - Control Group The first group will act as the control group and will receive wound infiltration with the full amount of local anaesthetic (40mls) around the drain sites and axillary wound, if present, as is standard practice. They will also receive a 20ml injection of 0.9% saline deep to serratus anterior under direct observation. Infiltration of saline will be delivered into 2-3 muscular slips (typically ribs 4-6) in the anterior axillary line. The local anaesthetic will be prepared according to body weight and a dose of 0.375% of chirocaine will be used with the addition of 1:200000 adrenaline and 1 microgram/kg of clonidine.
Group 2 - Serratus Plane Block Group
The second group will receive a serratus plane block and wound infiltration as described below:
The serratus plane block will be conducted by injecting 50% of the total available chirocaine 0.375% with adrenaline and clonidine (20mls) deep to serratus anterior under direct observation. Infiltration will be delivered into 2-3 muscular slips (typically ribs 4-6) in the anterior axillary line. The remaining 50% of local anaesthetic (20mls) will be administered by wound infiltration around the drain sites and axillary wound if present along with a 20ml 0.9% saline injection.
For clarity, please see the table summary below detailing the volumes and locations of local anaesthetic and saline injections in both groups:
20ml local anaesthetic delivered as a serratus block 20ml Saline delivered deep to serratus anterior 20ml local anaesthetic and 20ml saline wound and drain site infiltration 40ml local anaesthetic wound and drain site infiltration Control Group X √ X √ Serratus Group √ X √ X
The purpose of the saline injections is to blind the trial to the surgeon delivering the serratus block.
The anaesthesia for all patients in both groups will be induced using a combination of 0.25mg/kg ketamine, propofol and fentanyl according to standard anaesthetic protocol. All patients will receive 10mg IM morphine intraoperatively. All patients will have regular simple analgesia such as paracetamol and ibuprofen and PRN opiates (tramadol 50-100mg PRN 8 hourly) prescribed for post-operative adjunct pain management.
Patients will be blinded to which group they are randomly allocated to. Written consent and information sheets will be provided to patients and a letter sent to their GP confirming participation in the study.
Data on pain scores and the use of analgesia in recovery, the use of analgesia overnight, the presence of nausea and the pain score and mobilisation status one day after the operation will be collected. The pain score will be assessed using a standard numerical rating scale from 0-10 to score their pain subjectively where:
- 0 = No Pain
- 1-3 = Mild Pain (interferes a little with activities of daily living)
- 4-6 = Moderate Pain (interferes significantly with activities of daily living)
- 7-10 = Severe Pain (unable to perform activities of daily living)
Patients will also be followed up and one week and 3 months after their surgery to determine their recovery and the presence of any pain. This data will be collected using the FACT - B: Quality of Life Assessment 1 questionnaire.
All collected data will only be stored on NHS trust computer systems.
Study design
- Primary purpose
- Supportive care
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Patients who undergo mastectomy +/- sentinel node biopsy +/- axillary clearance +/- implant reconstruction will be eligible for the study
Key exclusion criteria (1 listed)
- Patients under the age of 18.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Local anaesthetic - chirocaine | Drug | – |
Primary outcome
To assess the serratus plane block's effectiveness in the management of post operative pain following mastectomy when compared to wound infiltration alone
Time frame: 18 months
1 secondary outcome
To determine the proportion of patients receiving a serratus plane block during mastectomy who go on to develop chronic pain syndromes compared to patients receiving wound infiltration alone
Time frame: 18 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Sep 2015.
Related trials for Post-operative Pain
Not yet recruiting
Post-operative Pain and Clinical Outcome After Single-cone Obturation With a Calcium Silicate-based Versus Epoxy Resin Sealer
Post Operative Pain, Acute, Irreversible Pulpitis (Toothache)
RecruitingPhase 2
Phenotype-based Model for Managing Chronic Post-treatment Pain Among Head and Neck Cancer Survivors: a Pilot Study
Chronic Postsurgical Pain, Chronic Post Cancer Surgery Pain
Active, not recruitingPhase 1
Comparison of Analgesic Efficacy Between Ultrasound Guided Serratus Anterior Plane Block or Thoracic Paravertebral Block Versus Intravenous Fentanyl for On-pump Coronary Artery Bypass Graft Surgery
Intra and Post Operative Pain Management, Fast Track Program,(Enhanced Recovery After Surgery (ERAS))
RecruitingPhase 4
The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery
Pain, Post Operative Analgesia
Not yet recruitingPhase 4
Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine in Ultrasound-Guided Sphenopalatine Ganglion Block for Functional Endoscopic Sinus Surgery
Post Operative Pain, Emergence Agitation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Local anaesthetic - chirocaine in people with Post-operative Pain and Serratus Block, run by Kingston Hospital NHS Trust.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 21 Sep 2015. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To assess the serratus plane block's effectiveness in the management of post operative pain following mastectomy when compared to wound infiltration alone (time frame: 18 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2015; AzTrials last refreshed its copy on 7 Nov 2026.